{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:12:29Z","timestamp":1761862349449,"version":"build-2065373602"},"reference-count":130,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.otc.2022.09.008","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T07:28:50Z","timestamp":1666423730000},"page":"107-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Aspirin-Exacerbated Respiratory Disease and the Unified Airway"],"prefix":"10.1016","volume":"56","author":[{"given":"Benjamin K.","family":"Walters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B.","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohit D.","family":"Divekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Willson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janalee K.","family":"Stokken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos D.","family":"Pinheiro-Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin K.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garret","family":"Choby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.otc.2022.09.008_bib1","first-page":"281","article-title":"Concerning the nature of intolerance to aspirin","volume":"40","author":"Samter","year":"1967","journal-title":"J\u00a0Allergy"},{"key":"10.1016\/j.otc.2022.09.008_bib2","doi-asserted-by":"crossref","first-page":"975","DOI":"10.7326\/0003-4819-68-5-975","article-title":"Intolerance to aspirin. Clinical studies and consideration of its pathogenesis","volume":"68","author":"Samter","year":"1968","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11882-020-00905-9","article-title":"NSAID-ERD Syndrome: the new hope from prevention, early diagnosis and new therapeutic targets","volume":"20","author":"Laidlaw","year":"2020","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib4","first-page":"1061","article-title":"Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin exacerbated respiratory disease","volume":"5","author":"Stevens","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/alr.22516","article-title":"Aspirin-exacerbated respiratory disease: longitudinal assessment of a large cohort and implications of diagnostic delay","volume":"10","author":"Kshirsagar","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jaci.2006.07.024","article-title":"Clinical and pathologic perspectives on aspirin sensitivity and asthma","volume":"118","author":"Stevenson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.otc.2022.09.008_bib7","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1056\/NEJMra1712125","article-title":"Aspirin-exacerbated respiratory disease","volume":"379","author":"White","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib8","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma. AIANE Investigators. European network on aspirin-induced asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Resp J"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1177\/19458924211056294","article-title":"Demographic variation in chronic rhinosinusitis by subtype and region: a systematic review","volume":"36","author":"Ma","year":"2022","journal-title":"Am J Rhinol Allergy"},{"issue":"12","key":"10.1016\/j.otc.2022.09.008_bib10","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/alr.22412","article-title":"Longitudinal progression of aspirin-exacerbated respiratory disease: analysis of a national insurance claims database","volume":"9","author":"Roland","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib11","first-page":"203","article-title":"The importance of timely diagnosis of aspirin-exacerbated respiratory disease for patient health and safety","volume":"6","author":"Buchheit","year":"2020","journal-title":"World J Otorhinolaryngol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib12","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/lio2.387","article-title":"Aspirin-exacerbated respiratory disease: A review","volume":"5","author":"Dominas","year":"2020","journal-title":"Laryngoscope Investig Otolaryngol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jaci.2021.06.018","article-title":"Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease","volume":"148","author":"Haque","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s00405-016-4366-x","article-title":"Olfaction and sino-nasal symptoms in patients with CRSwNP and AERD and without AERD: a cross-sectional and longitudinal study","volume":"274","author":"Gudziol","year":"2017","journal-title":"Eur Arch Ororhinolaryngol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib15","first-page":"1174","article-title":"A\u00a0one-day, 90-minute aspirin challenge and desensitization protocol in aspirin-exacerbated respiratory disease","volume":"7","author":"DeGregorio","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib16","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaci.2018.10.007","article-title":"Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease","volume":"143","author":"Cahill","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib17","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jaip.2017.08.029","article-title":"ASA challenge in children with hypersensitivity reactions to NSAIDs differentiate between cross-intolerant and selective responders","volume":"6","author":"Blanca-Lopez","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/all.13599","article-title":"Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) -- a EAACI position paper","volume":"74","author":"Kowalski","year":"2019","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaip.2013.12.003","article-title":"Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease","volume":"2","author":"Cardet","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2022.09.008_bib20","first-page":"S27","article-title":"Diagnosis of asthma: diagnostic testing","volume":"5","author":"Brigham","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib21","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/alr.22741","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis 2021","volume":"11","author":"Orlandi","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1945892420941732","article-title":"A\u00a0comparison of sphenoid sinus osteoneogenesis in aspirin-exacerbated respiratory disease","volume":"35","author":"Malfitano","year":"2021","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.rmr.2014.04.100","article-title":"Aspirin hypersensitivity: characteristics and diagnostic approach [in French]","volume":"32","author":"Baudrand","year":"2015","journal-title":"Rev Mal Respir"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2013.34.3670","article-title":"The clinical dilemma of \"silent desensitization\" in aspirin-exacerbated respiratory disease","volume":"34","author":"White","year":"2013","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib25","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jaci.2020.10.043","volume":"147","author":"Stevens","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jaci.2021.06.009","article-title":"Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease","volume":"148","author":"Cahill","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60012-9","article-title":"Intranasal ketorolac challenge for the diagnosis of aspirin-exacerbated respiratory disease","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib28","first-page":"45","article-title":"Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management","volume":"7","author":"Li","year":"2019","journal-title":"Med Sci"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaci.2017.05.006","article-title":"Safety and outcomes of aspirin desensitization for aspirin-exacerbated respiratory disease: a single center study","volume":"141","author":"Waldram","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8851","key":"10.1016\/j.otc.2022.09.008_bib30","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/0140-6736(93)91073-U","article-title":"Leukotriene-E(4) and granulocytic infiltration into asthmatic airways","volume":"341","author":"Laitinen","year":"1993","journal-title":"Lancet"},{"issue":"3 Pt 1","key":"10.1016\/j.otc.2022.09.008_bib31","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0091-6749(99)70324-6","article-title":"Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses","volume":"104","author":"Daffern","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2022.09.008_bib32","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/lary.29137","article-title":"Elevated urine leukotriene E4 is associated with worse objective markers in nasal polyposis patients","volume":"131","author":"Choby","year":"2020","journal-title":"Laryngoscope"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/01945998211011060","article-title":"Urine leukotriene E4: implications as a biomarker in chronic rhinosinusitis","volume":"166","author":"Choby","year":"2022","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"13\u201314","key":"10.1016\/j.otc.2022.09.008_bib34","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.clinbiochem.2016.02.007","article-title":"Analytical and clinical validation of an LC-MS\/MS method for urine leukotriene E4: a marker of systemic mastocytosis","volume":"49","author":"Lueke","year":"2016","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib35","first-page":"665","article-title":"Diagnostic utility of urinary LTE4 in asthma, allergic rhinitis, chronic rhinosinusitis, nasal polyps, and aspirin sensitivity","volume":"4","author":"Divekar","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","article-title":"Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis","volume":"113","author":"Higashi","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.otc.2022.09.008_bib37","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1940-6207.CAPR-13-0083","article-title":"Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers","volume":"6","author":"Mohebati","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib38","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/1945892420912362","article-title":"Symptom control of patients with chronic rhinosinusitis with nasal polyps under maintenance therapy with daily acetylsalicylic acid","volume":"34","author":"Hahn","year":"2020","journal-title":"Am J Rhinol Allergy"},{"issue":"9","key":"10.1016\/j.otc.2022.09.008_bib39","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1002\/alr.22604","article-title":"Complete endoscopic sinus surgery followed by aspirin desensitization is associated with decreased overall corticosteroid use","volume":"10","author":"Bosso","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib40","first-page":"990","article-title":"Urinary leukotriene E4 to determine aspirin intolerance in asthma: a systematic review and meta-analysis","volume":"5","author":"Hagan","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"19","key":"10.1016\/j.otc.2022.09.008_bib41","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa013508","article-title":"Leukotriene receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis","volume":"347","author":"Sousa","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jaci.2014.07.031","article-title":"Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease","volume":"135","author":"Cahill","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2022.09.008_bib43","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMcibr1514013","article-title":"Aspirin-exacerbated respiratory disease - new prime suspects","volume":"374","author":"Laidlaw","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2\u20133","key":"10.1016\/j.otc.2022.09.008_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0005-2760(92)90299-B","article-title":"Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations","volume":"1128","author":"Antoine","year":"1992","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib45","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.LAB.0000062851.71286.47","article-title":"Human platelets produce granulocyte-macrophage colony-stimulating factor and delay eosinophil apoptosis","volume":"83","author":"Raiden","year":"2003","journal-title":"Lab Investig"},{"issue":"7","key":"10.1016\/j.otc.2022.09.008_bib46","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1111\/all.14720","article-title":"Mass cytometry reveals unique subsets of T\u00a0cells and lymphoid cells in nasal polyps from patients with chronic rhinosinusitis (CRS)","volume":"76","author":"Bartemes","year":"2021","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.otc.2022.09.008_bib47","doi-asserted-by":"crossref","first-page":"103025","DOI":"10.1016\/j.amjoto.2021.103025","article-title":"Pre-intervention SNOT-22 scores predict outcomes in aspirin exacerbated respiratory disease","volume":"42","author":"Kuan","year":"2021","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib48","first-page":"207","article-title":"Olfactory outcomes in the management of aspirin exacerbated respiratory disease related chronic rhinosinusitis","volume":"6","author":"Spielman","year":"2020","journal-title":"World J Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.otc.2022.09.008_bib49","first-page":"1580","article-title":"Sinus surgery is associated with a decrease in aspirin-induced reaction severity in AERD patients","volume":"7","author":"Jerschow","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.otc.2022.09.008_bib50","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/alr.22418","article-title":"Endoscopic sinus surgery improves aspirin treatment response in AERD patients","volume":"9","author":"Shah","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1177\/0194599816640723","article-title":"The role of surgery in management of Samter's Triad: a systematic review","volume":"155","author":"Adelman","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib52","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/alr.22487","article-title":"Revision surgery rates in chronic rhinosinusitis with nasal polyps: a meta-analysis of risk factors","volume":"10","author":"Loftus","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"8","key":"10.1016\/j.otc.2022.09.008_bib53","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/alr.21541","article-title":"Outcomes of complete vs targeted approaches to endoscopic sinus surgery","volume":"5","author":"DeConde","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib54","first-page":"235","article-title":"Appropriate extent of surgery for aspirin-exacerbated respiratory disease","volume":"6","author":"Muhonen","year":"2020","journal-title":"World J Otorhinolaryngol"},{"issue":"10","key":"10.1016\/j.otc.2022.09.008_bib55","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1002\/alr.22626","article-title":"Surgical outcomes in aspirin-exacerbated respiratory disease without aspirin desensitization","volume":"10","author":"Grose","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"9","key":"10.1016\/j.otc.2022.09.008_bib56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/alr.22634","article-title":"Aspirin-exacerbated respiratory disease: personalized medical and surgical approaches","volume":"10","author":"Schlosser","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"6","key":"10.1016\/j.otc.2022.09.008_bib57","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1016\/j.jaip.2021.01.032","article-title":"Multidisciplinary single-center outcomes compared to two-center outcomes for the treatment of aspirin exacerbated respiratory disease","volume":"9","author":"Bosso","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib58","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/lary.26794","article-title":"Evolution of the endoscopic modified Lothrop procedure: A systematic review and meta-analysis","volume":"128","author":"Shih","year":"2018","journal-title":"Laryngoscope"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/lary.23610","article-title":"Role of frontal sinus surgery in nasal polyp recurrence","volume":"123","author":"Bassiouni","year":"2013","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.otc.2022.09.008_bib60","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/alr.21739","article-title":"Outcomes of modified endoscopic Lothrop in aspirin-exacerbated respiratory disease with nasal polyposis","volume":"6","author":"Morrissey","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib61","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/alr.22032","article-title":"Equivalence in outcomes between Draf 2B vs Draf 3 frontal sinusotomy for refractory chronic frontal rhinosinusitis","volume":"8","author":"Patel","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"10.1016\/j.otc.2022.09.008_bib62","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/lary.27016","article-title":"The \"Cross-court draf IIb\" procedure for advanced nasal septum or frontal sinus pathology and nasal septum pathology","volume":"128","author":"Choby","year":"2018","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib63","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/alr.22228","article-title":"Draf IIB with superior septectomy: finding the \"middle ground","volume":"9","author":"Bhalla","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib64","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/alr.22520","article-title":"Aspirin desensitization therapy in aspirin-exacerbated respiratory disease: a review","volume":"10","author":"Larivee","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/alr.21678","article-title":"A\u00a0novel treatment adjunct for aspirin exacerbated respiratory disease: the low-salicylate diet: a multicenter randomized control crossover trial","volume":"6","author":"Sommer","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"12","key":"10.1016\/j.otc.2022.09.008_bib66","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/alr.21826","article-title":"Contemporary management of chronic rhinosinusitis with nasal polyposis in aspirin exacerbated respiratory disease: an evidence-based review with recommendations","volume":"6","author":"Levy","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib67","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaip.2017.10.011","article-title":"Dietary fatty acid modification for the treatment of Aspirin-Exacerbated Respiratory Disease: a prospective pilot trial","volume":"6","author":"Schneider","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2005.10.012","article-title":"Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma","volume":"117","author":"Zeiger","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib69","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.165.1.2010080","article-title":"Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial","volume":"165","author":"Dahlen","year":"2002","journal-title":"Am J Resp Crit Care Med"},{"issue":"9","key":"10.1016\/j.otc.2022.09.008_bib70","first-page":"3170","article-title":"Leukotriene-associated rash in aspirin-exacerbated respiratory disease","volume":"8","author":"Laidlaw","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.otc.2022.09.008_bib71","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jaip.2015.03.001","article-title":"Survey-defined patient experiences with aspirin-exacerbated respiratory disease","volume":"3","author":"Von","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4 Pt 1","key":"10.1016\/j.otc.2022.09.008_bib72","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1164\/ajrccm.157.4.9707089","article-title":"Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics","volume":"147","author":"Dahlen","year":"1998","journal-title":"Am J Resp Crit Care Med"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2016.12.924","article-title":"Efficacy of zileuton in patients with asthma and history of aspirin sensitiity: a retrospective analysis of data from two phase 3 studies","volume":"139","author":"Laidlaw","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib74","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaip.2020.07.052","article-title":"Risk of psychiatric adverse events among montelukast users","volume":"9","author":"Sansing-Foster","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"9","key":"10.1016\/j.otc.2022.09.008_bib75","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2165\/00002018-200730090-00006","article-title":"Clinical pattern of zileuton-associated liver injury: results of a 12-month study in patients with chronic asthma","volume":"30","author":"Watkins","year":"2007","journal-title":"Drug Saf"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib76","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/ACI.0000000000000796","article-title":"Updates on treatment options in aspirin exacerbated respiratory disease","volume":"22","author":"Ramos","year":"2022","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib77","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2500\/aap.2021.42.210002","article-title":"Effectiveness of endoscopic sinus surgery and aspirin therapy in the management of aspirin-exacerbated respiratory disease","volume":"42","author":"Sweis","year":"2021","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib78","first-page":"220","article-title":"Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"6","author":"Ryan","year":"2020","journal-title":"World J Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.otc.2022.09.008_bib79","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaip.2015.06.013","article-title":"An Hourly Dose-Escalation Desensitization Protocol for Aspirin-Exacerbated Respiratory Disease","volume":"3","author":"Chen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib80","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaip.2018.08.004","article-title":"Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease","volume":"7","author":"Pelletier","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib81","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.anl.2018.12.002","article-title":"Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: a prospective cohort study","volume":"46","author":"Cooper","year":"2019","journal-title":"Auris Nasus Larynx"},{"issue":"10","key":"10.1016\/j.otc.2022.09.008_bib82","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/alr.22665","article-title":"Age as a factor in treatment of aspirin-exacerbated respiratory disease: relationship to required aspirin maintenance dose after desensitization","volume":"10","author":"Locke","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.otc.2022.09.008_bib83","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1164\/ajrccm\/140.1.148","article-title":"Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma","volume":"140","author":"Arm","year":"1989","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/alr.22036","article-title":"Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"8","author":"Adappa","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib85","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0194599814545750","article-title":"Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease","volume":"151","author":"Cho","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/0194599820932137","article-title":"Meta-analysis exploring sinopulmonary outcomes on aspirin desensitization in aspirin-exacerbated respiratory disease","volume":"164","author":"Chaaban","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anai.2021.05.005","article-title":"Dupilumab improves alcohol tolerance in aspirin-exacerbated respiratory disease","volume":"127","author":"Arnold","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib88","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/alr.22709","article-title":"Aspirin desensitization for aspirin-exacerbated respiratory disease in the era of biologics: clinical perspective","volume":"11","author":"Bosso","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1067\/mai.2003.7","article-title":"Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease","volume":"111","author":"Berges-Gimeno","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib90","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/alr.22643","article-title":"Major complications of aspirin desensitization and maintenance therapy in aspirin-exacerbated respiratory disease","volume":"11","author":"Sweis","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib91","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/alr.22900","article-title":"Outcomes of aspirin exacerbated respiratory disease in patients treated with aspirin desensitization and biologics","volume":"12","author":"D'Souza","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"7","key":"10.1016\/j.otc.2022.09.008_bib92","first-page":"2910","article-title":"Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Ra in a real-world setting","volume":"9","author":"Bavaro","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"26","key":"10.1016\/j.otc.2022.09.008_bib93","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.otc.2022.09.008_bib94","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1165\/rcmb.2009-0220TR","article-title":"The cytokine network in chronic obstructive pulmonary disease","volume":"41","author":"Barnes","year":"2009","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib95","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jaci.2021.09.009","article-title":"Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis","volume":"149","author":"Oykhman","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.otc.2022.09.008_bib96","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jaip.2019.03.044","article-title":"Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD","volume":"7","author":"Laidlaw","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"10209","key":"10.1016\/j.otc.2022.09.008_bib97","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib98","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaip.2021.09.030","article-title":"Appraisal of the real-world effectiveness of biologic therapies in aspirin-exacerbated respiratory disease","volume":"10","author":"Wangberg","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib99","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/1945892420961969","article-title":"Dupilumab as add-on therapy for chronic rhinosinusitis for nasal polyposis in aspirin exacerbated respiratory disease","volume":"35","author":"Mustafa","year":"2021","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib100","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.anai.2021.11.020","article-title":"Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease","volume":"128","author":"Patel","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib101","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaci.2021.06.019","article-title":"Immunology-based recommendations for available and upcoming biologics in aspirin-exacerbated respiratory disease","volume":"148","author":"Buchheit","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib102","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaip.2018.01.038","article-title":"A\u00a0retrospective analysis of mepolizumab in patients with aspirin-exacerbated respiratory disease","volume":"6","author":"Tuttle","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib103","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jaci.2021.05.043","article-title":"Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease","volume":"148","author":"Buchheit","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.otc.2022.09.008_bib104","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S2213-2600(21)00097-7","article-title":"Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Han","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib105","first-page":"230","article-title":"Biologic therapies versus surgical management for aspirin-exacerbated respiratory disease: a review of preliminary data, efficacy, and cost","volume":"6","author":"Workman","year":"2020","journal-title":"World J Otorhinolaryngol"},{"issue":"5","key":"10.1016\/j.otc.2022.09.008_bib106","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.jaci.2015.09.034","article-title":"Omalizumab reduces cysteinyl leukotriene and 9\u03b1,11\u03b2-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease","volume":"137","author":"Hayashi","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"12","key":"10.1016\/j.otc.2022.09.008_bib107","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1164\/rccm.201906-1215OC","article-title":"Omalizumab for aspirin hypersensitivity and leukotriene overproduction in aspirin-exacerbated respiratory disease: a randomized controlled trial","volume":"201","author":"Hayashi","year":"2020","journal-title":"Am J Resp Crit Care Med"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib108","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaci.2020.05.032","article-title":"Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials","volume":"146","author":"Gevaert","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib109","first-page":"506","article-title":"Omalizumab-induced aspirin tolerance in nonsteroidal anti-inflammatory drug-exacerbated respiratory disease patients is independent of atopic sensitization","volume":"10","author":"Quint","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.otc.2022.09.008_bib110","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.anai.2020.08.008","article-title":"Aspirin desensitization vs biologics for patients with aspirin-exacerbated respiratory disease","volume":"126","author":"Laidlaw","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.otc.2022.09.008_bib111","article-title":"Economic Evaluation of Dupilumab Versus Endoscopic Sinus Surgery for the Treatment of Chronic Rhinosinusitis With Nasal Polyps","author":"Parasher","year":"2021","journal-title":"Int Forum Allergy Rhinol"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib112","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4193\/Rhin17.029","article-title":"Chronic rhinosinusitis severity is associated with need for asthma-related systemic corticosteroids","volume":"55","author":"Phillips","year":"2017","journal-title":"Rhinology"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib113","first-page":"323","article-title":"Chronic rhinosinusitis exacerbations are differentially associated with lost productivity based on asthma status","volume":"56","author":"Phillips","year":"2018","journal-title":"Rhinology"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib114","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.otc.2022.09.008_bib115","first-page":"15","article-title":"Etiology of nasal polyps associated with aspirin-sensitive asthma","volume":"8","author":"Yamashita","year":"1989","journal-title":"Rhinol Suppl"},{"key":"10.1016\/j.otc.2022.09.008_bib116","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/lary.24418","article-title":"Analysis of Comorbidities and Objective Parameters in Refractory Chronic Rhinosinusitis","volume":"123","author":"Batra","year":"2013","journal-title":"Laryngoscope"},{"issue":"5","key":"10.1016\/j.otc.2022.09.008_bib117","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.rmed.2015.02.015","article-title":"Factors associated with asthma control in patients with aspirin-exacerbated respiratory disease","volume":"109","author":"Bochenek","year":"2015","journal-title":"J\u00a0Respir Med"},{"issue":"3","key":"10.1016\/j.otc.2022.09.008_bib118","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/all.13048","article-title":"Asthma quality of life and control after sinus surgery in patients with chronic rhinosinusitis","volume":"72","author":"Schlosser","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib119","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1183\/09031936.06.00043305","article-title":"Treatment of chronic rhinosinusitis and its effects on asthma","volume":"28","author":"Ragab","year":"2006","journal-title":"Eur Resp J"},{"key":"10.1016\/j.otc.2022.09.008_bib120","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/000348949910800407","article-title":"Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis","volume":"108","author":"Ikeda","year":"1999","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"4","key":"10.1016\/j.otc.2022.09.008_bib121","first-page":"337","article-title":"Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial","volume":"10","author":"Lourijsen","year":"2022","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.otc.2022.09.008_bib122","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jaip.2014.09.009","article-title":"Aspirin or Other Nonsteroidal Inflammatory Agent Exacerbated Asthma","volume":"2","author":"Ledford","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.otc.2022.09.008_bib123","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1177\/0003489420905859","article-title":"Patient Satisfaction and Efficiency Benefits of a Novel Multidisciplinary Rhinology and Allergy Clinic","volume":"129","author":"Li","year":"2020","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib124","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jaci.2013.07.004","article-title":"Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis","volume":"133","author":"Bochenek","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"16","key":"10.1016\/j.otc.2022.09.008_bib125","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1182\/blood-2011-10-384826","article-title":"Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes","volume":"119","author":"Laidlaw","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.otc.2022.09.008_bib126","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jaci.2018.06.001","article-title":"A\u00a0trial of P2Y12 receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease","volume":"143","author":"Laidlaw","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"10","key":"10.1016\/j.otc.2022.09.008_bib127","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in Adults with Uncontrolled Asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.otc.2022.09.008_bib128","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"22","key":"10.1016\/j.otc.2022.09.008_bib129","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1402895","article-title":"Effects of an anti-TSLP antibody on allergen-induced asthmatic responses","volume":"370","author":"Gauvreau","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.otc.2022.09.008_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2022.03.001","article-title":"Fevipiprant in CRSwNP and comorbid asthma: wrong target population or wrong PGD2 receptor?","author":"Cahill","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003066652200130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003066652200130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T14:54:27Z","timestamp":1758466467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003066652200130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S003066652200130X"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2022.09.008","relation":{},"ISSN":["0030-6665"],"issn-type":[{"type":"print","value":"0030-6665"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin-Exacerbated Respiratory Disease and the Unified Airway","name":"articletitle","label":"Article Title"},{"value":"Otolaryngologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.otc.2022.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}